ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED > Summary
Court Case Number 3:25-cv-00230
Filing Date Jan 9, 2025
Termination Date Jun 6, 2025
Court New Jersey District Court
Status Statistical Closing
JudgesRobert Kirsch
Defendant
Plaintiff Attorneys
Defendant Attorneys
Natco Pharma Ltd.
Attorney Name: James Richter
Midlige Richter
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 12178816 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Dec 31, 2024 |
| 11633396 | Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one | Apr 25, 2023 |
| 08859562 | Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer | Oct 14, 2014 |
| 08475842 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Jul 2, 2013 |
| 07449464 | Phthalazinone derivatives | Nov 11, 2008 |
